UNIKUM Therapeutics ApS — Credit Rating and Financial Key Figures

UNIKUM Therapeutics ApS (CVR number: 41192925) is a company from AARHUS. The company recorded a gross profit of -7465.4 kDKK in 2023. The operating profit was -15.4 mDKK, while net earnings were -14.9 mDKK. The profitability of the company measured by Return on Assets (ROA) was -79.6 %, which can be considered poor and Return on Equity (ROE) was -421.7 %, which can be considered poor. The equity ratio, a key indicator for solidity, stood at -80.3 %. This indicates that the company's debt surpasses the value of its total assets, posing significant financial risk. UNIKUM Therapeutics ApS's liquidity measured by quick ratio was 2.3 which is at a very high level. Thus, the company demonstrates exceptional financial stability, possessing a significant surplus of liquid assets over its short-term liabilities.